Open House – Global Healthcare 2021

Tuesday, 26-Jan-2021 10:00 to Thursday, 28-Jan-2021 00:00

Open House – Global Healthcare 2021

January 21 – 23 (GMT)

Joined by 35 CEOs,  buy- and sell-side analysts, regulatory specialists and investment banks in both the United States and Europe over three days. What exactly were the key themes that emerged from this year’s Global Healthcare event?

Here are five investment themes curated by Vivienne Parry OBE, science author, BBC journalist and host of Edison Open House Global Healthcare 2021.


Theme 1: Pioneering gene and cell-based therapies

Cell-therapy technology, cellular medicines, gene therapies, stem-cell therapies and aquaculture genetics.

Learn more about the companies via the links below:
ReNeuron Group | Oxford Biomedica | Mesoblast | MaxCyte | Benchmark Holdings

Theme 2: Diagnostics and drug-delivery innovation

Cancer screening, kidney-transplant tests, antibiotic stewardship, medicine bio-delivery, transdermal drug delivery, exosome medicines and in-vitro diagnostics.

Learn more about the companies via the link below:
VolitionRx | Verici Dx | OpGen | Midatech Pharma| Medherant | Exopharm | BioPorto Diagnostics

Theme 3: Cutting-edge technology and medical devices

Lab-automation solutions, bionic vision, orthobiologics, AI for mammography and development of the world’s first total artificial heart.

Learn more about the companies via the links below:
Pixium Vision | Locate Bio | Creo Medical | Carmat

Theme 4: Pharmaceutical innovation

Psilocybin-based therapeutics, drugs for GI and infectious diseases, ocular health, CBD health, CRO and hormone therapeutics.

Learn more about the companies via the links below:
Tryp Therapeutics | RedHill Biopharma | Nicox | MGC Pharmaceuticals | Ergomed | Diurnal Group

Theme 5: New treatments for cancer and other life-threatening diseases

Novel immunotherapies, nuclear medicine, small-molecule drug discovery, epigenetics, precision-targeted drugs and antibody therapies.

Learn more about the companies via the links below:
Ultimovacs | Telix Pharmaceuticals | Oryzon Genomics | Onxeo | Kazia Therapeutics | Cantargia

Want more healthcare content from Edison?
Subscribe here >

Registration for this event is now closed.

Share this with friends and colleagues